Children with IgA vasculitis who present with severe skin manifestations may be at higher risk for relapse and should be followed up for at least 1 year.

InvestigateTV+ shares a young mother’s struggle with the debilitating effects of lupus. Plus, we take an in-depth look at what could become a breakthrough treatment.

Fast Track designation reflects the unmet need in this serious disease and enables the potential for an accelerated FDA review timeline The designation is supported ...

These results suggest that ruxolitinib cream offers high levels of clinical efficacy, including deep and rapid responses, ...